Technical Analysis for SVA - Sernova Corp.

Grade Last Price % Change Price Change
F 0.540 -3.57% -0.020
SVA closed down 3.57 percent on Thursday, March 28, 2024, on 64 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Gapped Down Weakness 0.00%
MACD Bullish Signal Line Cross Bullish -3.57%
Outside Day Range Expansion -3.57%
Gapped Down Weakness -3.57%
MACD Bearish Signal Line Cross Bearish -1.82%
Narrow Range Bar Range Contraction -1.82%
20 DMA Resistance Bearish -1.82%
180 Bearish Setup Bearish Swing Setup -1.82%
Gapped Down Weakness -1.82%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Sernova Corp. Description

Sernova Corp. is a development-stage regenerative medicine company. The Company is engaged in the development of its Cell Pouch and associated technologies, including therapeutic cells for the treatment of chronic diseases and local immune protection technologies. It is focused on developing a treatment for insulin-dependent human diabetes and other metabolic, blood and neurological diseases with therapeutic cells placed into its implanted and prevascularized medical device (the Cell Pouch), protected from immune system attack. The Cell Pouch is designed to create a microvessel rich, tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the treatment of chronic diseases, such as diabetes and thyroid disease. Its lead program is the clinical development of the Cell Pouch for treatment of patients with insulin dependent diabetes. It is also evaluating Cell Pouch for the treatment of patients with hemophilia A.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinic Emerging Technologies Disease RTT Biology Diseases Diabetes Plantation Immune System Proteins Regenerative Medicine Stem Cells Neurological Diseases Diabetes Mellitus Graft Hormone Transplantation

Is SVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.15
52 Week Low 0.51
Average Volume 129,441
200-Day Moving Average 0.746
50-Day Moving Average 0.598
20-Day Moving Average 0.569
10-Day Moving Average 0.568
Average True Range 0.033
RSI (14) 40.83
ADX 18.6
+DI 13.035
-DI 15.552
Chandelier Exit (Long, 3 ATRs) 0.530
Chandelier Exit (Short, 3 ATRs) 0.630
Upper Bollinger Bands 0.608
Lower Bollinger Band 0.529
Percent B (%b) 0.14
BandWidth 13.755
MACD Line -0.015
MACD Signal Line -0.014
MACD Histogram -0.001
Fundamentals Value
Market Cap 112.46 Million
Num Shares 208 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -28.42
Price-to-Sales 0.00
Price-to-Book 38.62
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.585
Resistance 3 (R3) 0.590 0.580 0.578
Resistance 2 (R2) 0.580 0.569 0.578 0.575
Resistance 1 (R1) 0.560 0.561 0.555 0.555 0.572
Pivot Point 0.550 0.550 0.548 0.548 0.550
Support 1 (S1) 0.530 0.539 0.525 0.525 0.508
Support 2 (S2) 0.520 0.531 0.518 0.505
Support 3 (S3) 0.500 0.520 0.503
Support 4 (S4) 0.495